BioSpace

GSK, Ionis hepatitis B functional cure breaks open market for followers

The approval of Hibsago has created a new market for a handful of biopharmas, including Gilead, Arrowhead, and Vir, to fill in.

By BioSpace

1 min read
GSK, Ionis hepatitis B functional cure breaks open market for followers
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights